Shepherd, P <br/><br/>
Analysis of molecular breakpoint and m-RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival.  [electronic resource] 

 -  British journal of haematology  Mar 1995 
 - 546-54 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1048 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2141.1995.tb08362.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Base Sequence<br/>Female<br/>Fusion Proteins, bcr-abl--genetics<br/>Humans<br/>Interferon-alpha--therapeutic use<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--genetics<br/>Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative--genetics<br/>Male<br/>Middle Aged<br/>Molecular Sequence Data<br/>Oncogene Proteins--genetics<br/>Prognosis<br/>Prospective Studies<br/>Protein-Tyrosine Kinases<br/>Proto-Oncogene Proteins<br/>Proto-Oncogene Proteins c-bcr<br/>RNA Splicing<br/>RNA, Messenger--genetics<br/>RNA, Neoplasm--genetics<br/>Survival Rate<br/>Time Factors<br/>Transcription, Genetic--genetics